Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial
BackgroundITALUNG is contributing to the European evaluation of low-dose CT (LDCT) screening for lung cancer (LC).MethodsEligible subjects aged 55–69 years, smokers or ex-smokers (at least 20 pack-years in the last 10 years), were randomised to receive an annual invitation for LDCT screening for 4 y...
Saved in:
| Published in: | Thorax Vol. 72; no. 9; pp. 825 - 831 |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
BMJ Publishing Group LTD
01.09.2017
|
| Subjects: | |
| ISSN: | 0040-6376, 1468-3296, 1468-3296 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!